The global caspofungin market was valued at USD 646.65 million in 2025 and is expected to increase from USD 672.81 million in 2026 to USD 924.06 million by 2034, reflecting a compound annual growth rate (CAGR) of 4.05% during the forecast period from 2026 to 2034.
Caspofungin, an echinocandin-class antifungal medication, has become a critical therapeutic option for treating severe and...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek